Cargando…
DNA methylation: potential biomarker in Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC) is one of the most common cancers in the world and it is often associated with poor prognosis. Liver transplantation and resection are two currently available curative therapies. However, most patients cannot be treated with such therapies due to late diagnosis. This u...
Autores principales: | Mah, Way-Champ, Lee, Caroline GL |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022334/ https://www.ncbi.nlm.nih.gov/pubmed/24635883 http://dx.doi.org/10.1186/2050-7771-2-5 |
Ejemplares similares
-
Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways
por: Thurnherr, Thomas, et al.
Publicado: (2016) -
Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis
por: Mah, Way-Champ, et al.
Publicado: (2014) -
Correction: Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis
por: Mah, Way-Champ, et al.
Publicado: (2016) -
DNA methylation biomarkers for hepatocellular carcinoma
por: Fan, Guorun, et al.
Publicado: (2018) -
Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma
por: Zhang, Cheng, et al.
Publicado: (2016)